XML 265 R221.htm IDEA: XBRL DOCUMENT v3.22.4

List of principal companies included in the scope of consolidation during 2022 - Summary of Principal Investments Accounted for Using the Equity Method (Details)	12 Months Ended
	Dec. 31, 2022
GlaxoSmithKline Consumer Healthcare, L.P.
Disclosure of joint operations [line Items]
Financial interest in principal investments accounted for using the equity method	11.70%
Infraserv GmbH & Co. Höchst KG
Disclosure of joint operations [line Items]
Financial interest in principal investments accounted for using the equity method	31.20%
Maphar
Disclosure of joint operations [line Items]
Financial interest in principal investments accounted for using the equity method	48.30%
MCM Vaccine B.V.
Disclosure of joint operations [line Items]
Financial interest in principal investments accounted for using the equity method	50.00%
MSP Vaccine Company (formerly MCM company)
Disclosure of joint operations [line Items]
Financial interest in principal investments accounted for using the equity method	50.00%
EUROAPI
Disclosure of joint operations [line Items]
Financial interest in principal investments accounted for using the equity method	30.10%

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfJointOperationsLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The proportion of ownership interest in a joint operation attributable to the entity. [Refer: Joint operations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2021-01-01
-Paragraph 21
-Subparagraph a
-Clause iv
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_21_a_iv&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_ProportionOfOwnershipInterestInJointOperation
Namespace Prefix:	ifrs-full_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_JointOperationsAxis=sny_GlaxoSmithKlineConsumerHealthcareLPMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_JointOperationsAxis=sny_InfraservGmbhAndCoHochstKGMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_JointOperationsAxis=sny_MapharMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_JointOperationsAxis=sny_MCMVaccineBVMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_JointOperationsAxis=sny_MSPVaccineCompanyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_JointOperationsAxis=sny_EuroapiMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: